Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:32 PM
Ignite Modification Date:
2025-12-24 @ 4:32 PM
NCT ID:
NCT03890666
Eligibility Criteria:
Inclusion Criteria:
* The participant has a documented diagnosis of asthma
* The participant is currently on treatment with an inhaled corticosteroid (ICS) with a long-acting beta2 antagonist (LABA).
* The participant is currently using inhaled albuterol sulfate as rescue medication and is willing to discontinue all other rescue medications and replace them with the study provided Albuterol eMDPI.
* The participant can read and communicate in English and is familiar with and is willing to use his/her own smart device and download and use the App.
* Additional criteria apply, please contact the investigator for more information
Exclusion Criteria:
* The participant has any clinically significant uncontrolled medical condition (treated or untreated) other than asthma.
* The participant was hospitalized for severe asthma in the last 30 days.
* The participant has a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) or Asthma-COPD Overlap (ACO).
* The participant is a current smoker or has a greater than 10 pack-year history of smoking.
* The participant is currently being treated with systemic corticosteroids (oral, intramuscular, or intravenous) or has been treated within the last 30 days.
* The participant has any treatment with biologics for asthma (for example, omalizumab, anti-IL5, anti-IL5R, anti-IL4R), or has had such treatment within the last 90 days.
* Additional criteria apply, please contact the investigator for more information
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
13 Years
Study:
NCT03890666
Study Brief:
Protocol Section:
NCT03890666